Abstract No. 358: Safety and tolerability of two dosing regimens of sorafenib in combination with locoregional therapy in patients with hepatocellular carcinoma
Freed, R., Min, J., Malik, S.B., Moshfegh, A., Vatakencherry, G.G.Volume:
23
Year:
2012
Language:
english
DOI:
10.1016/j.jvir.2011.12.477
File:
PDF, 56 KB
english, 2012